MLI Stock Overview
Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for MLI from our risk checks.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Mesa Laboratories, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$138.00 |
| 52 Week High | US$148.00 |
| 52 Week Low | US$78.00 |
| Beta | 0.83 |
| 1 Month Change | 4.55% |
| 3 Month Change | 42.27% |
| 1 Year Change | 44.50% |
| 3 Year Change | -38.39% |
| 5 Year Change | n/a |
| Change since IPO | -25.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| MLI | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | 2.2% | -0.9% | 2.7% |
| 1Y | 44.5% | -4.2% | 17.0% |
Return vs Industry: MLI exceeded the German Life Sciences industry which returned -4.2% over the past year.
Return vs Market: MLI exceeded the German Market which returned 17% over the past year.
Price Volatility
| MLI volatility | |
|---|---|
| MLI Average Weekly Movement | 6.4% |
| Life Sciences Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.1% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: MLI has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: MLI's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 736 | Gary Owens | www.mesalabs.com |
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries.
Mesa Laboratories, Inc. Fundamentals Summary
| MLI fundamental statistics | |
|---|---|
| Market cap | €754.67m |
| Earnings (TTM) | -€237.72m |
| Revenue (TTM) | €226.57m |
3.3x
P/S Ratio-3.2x
P/E RatioIs MLI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MLI income statement (TTM) | |
|---|---|
| Revenue | US$237.75m |
| Cost of Revenue | US$86.27m |
| Gross Profit | US$151.48m |
| Other Expenses | US$400.92m |
| Earnings | -US$249.44m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -45.91 |
| Gross Margin | 63.71% |
| Net Profit Margin | -104.92% |
| Debt/Equity Ratio | 126.1% |
How did MLI perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield-1%
Payout RatioDoes MLI pay a reliable dividends?
See MLI dividend history and benchmarks| Mesa Laboratories dividend dates | |
|---|---|
| Ex Dividend Date | Feb 28 2025 |
| Dividend Pay Date | Mar 17 2025 |
| Days until Ex dividend | 11 days |
| Days until Dividend pay date | 28 days |
Does MLI pay a reliable dividends?
See MLI dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/16 23:52 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Mesa Laboratories, Inc. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vijay Kumar | Evercore ISI |
| Paul Knight | Janney Montgomery Scott LLC |
| Tycho Peterson | Jefferies LLC |